$Seelos Therapeutics (SEEL.US)$BTIG analyst Thomas Shrader m...
$Seelos Therapeutics (SEEL.US)$BTIG analyst Thomas Shrader maintained a Buy rating on Seelos Therapeutics (SEEL – Research Report) yesterday and set a price target of $4.00.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
72186299 : What does that mean